Frencken (SGX:E28)'s FY25 revenue rose 8.9% y-o-y to S$865.1mil, exceeding our projections by 5%, reflecting a gradual recovery in semiconductor equipment demand and continued resilience across selected industrial and medical programmes.
3%-5% beat on revenue and earnings; margins remain resilient.
Semiconductor strength and resilient medical/automation demand outweighed softness in analytical life sciences and automotive.
- Read this at SGinvestors.io -
The semiconductor segment, which accounts for 49% of total revenue, delivered strong growth of 16.7% y-o-y, driven mainly by a sales rebound in Asia in tandem with recovering demand across certain semiconductor equipment categories.
Medical and industrial automation revenues also improved y-o-y, while analytical life sciences and automotive recorded softer performance compared with the prior year.
Earnings outlook remains constructive, semiconductor to strengthen from 2H26; automotive radar antenna solutions gaining traction.
Read more at SGinvestors.io.
Above is an excerpt from a report by DBS Group Research. Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.
